PŘEDÁVÁNÍ ÚDAJŮ Sample Clauses

PŘEDÁVÁNÍ ÚDAJŮ. Both prior to and during the course of the Study, the Investigator and the Study Personnel staff may provide PSI and/or the Sponsor with personal data. Such data may include names, contact information, bank account, work experience, qualifications, publications, resumés, educational background, performance information, facilities, staff capabilities, and other information relating to the Study (the “Personal Data”). The Investigator hereby consents to the processing (including use, disclosure or transfer) of his/her Personal Data by PSI, the Sponsor, their respective agents and affiliates and
Sample 1
AutoNDA by SimpleDocs
PŘEDÁVÁNÍ ÚDAJŮ. Both prior to and during the course of the Study, the Investigator and the Study Personnel staff may provide PSI and/or the Sponsor with personal data. Such data may include names, contact information, bank account, work experience, qualifications, publications, resumés, educational background, performance information, facilities, staff capabilities, and other information relating to the Study (the “Personal Data”). The Investigator hereby consents to the processing (including use, disclosure or transfer) of his/her Personal Data by PSI, the Sponsor, their respective agents and affiliates and governmental or regulatory agencies both in the Czech Republic and abroad for the following purposes (the “Purposes”): (a) the conduct of clinical trials; (b) review by governmental or regulatory agencies, PSI, the Sponsor and their agents, and affiliates; (c) satisfying legal or regulatory requirements; and, (d) storage in databases for use in selecting investigators and institutions for future clinical trials. The Investigator also agrees to a transfer of his/her Personal Data abroad, even if such personal data is transferred to third countries which do not ensure at least the same level of personal data protection in its territory as that in force in the territory of the European Union are not recognized by the EU Commission. The Investigator and the Institution represent that all Study Personnel have consented to the processing of their Personal Data for the Purposes, including the transfer to third counties, and shall notify PSI immediately if such consent has been withdrawn. Před i v průběhu Studie může být Hlavní zkoušející a Studijní personál požádán o poskytnutí osobních údajů PSI a (nebo)
Sample 1
PŘEDÁVÁNÍ ÚDAJŮ. Both prior to and during the course of the Study, the Investigator and the Study Personnel staff may provide PSI and/or the Sponsor with personal data. Such data may include names, contact information, bank account, work experience, qualifications, publications, resumés, educational background, performance information, facilities, staff capabilities, and other information relating to the Study (the “Personal Data”). The Institution acknowledges that the Investigator and the Study Personnel consent to the processing (including use, disclosure or transfer) of his/her Personal Data by PSI, the Sponsor, their respective agents and affiliates and governmental or regulatory agencies both in the Czech Republic and abroad for the following purposes (the “Purposes”): (a) the conduct of clinical trials; (b) review by governmental or regulatory agencies, PSI, the Sponsor and their agents, and affiliates; (c) satisfying legal or regulatory requirements; and, (d) storage in databases for use in selecting investigators and institutions for future clinical trials. The Institution also agrees that the Investigator and the Study Před i v průběhu Studie může být Hlavní zkoušející a Studijní personál požádán o poskytnutí osobních údajů PSI a (nebo)
Sample 1
PŘEDÁVÁNÍ ÚDAJŮ. Both prior to and during the course of the Study, the Investigator and the Study Personnel staff may provide PSI and/or the Sponsor with personal data. Such data may include names, contact information, work experience, qualifications, publications, resumés, educational background, performance information, facilities, staff capabilities, and other information relating to the Study (the “Personal Data”). The Investigator hereby consents to the processing (including use, disclosure or transfer) of his/her Personal Data by PSI, the Sponsor, their respective agents and affiliates and governmental or regulatory agencies both in the Czech Republic and abroad for the following purposes (the “Purposes”): (a) the conduct of clinical trials; (b) review by governmental or regulatory agencies, PSI, the Sponsor and their agents, and affiliates;
Sample 1
PŘEDÁVÁNÍ ÚDAJŮ. Each of Sponsor and Institution may transfer the Personal Data under this Agreement to its third parties to the extent such third parties have a legitimate need to process the Personal Data under this Agreement, provided that such transfers are subject to appropriate contractual restrictions and are made in accordance with Applicable Data Protection Law. The Sponsor and Institution shall not disclose or transfer Personal Data outside the European Economic Area without affording adequate protections for Personal Data in accordance with applicable Data Protection Law. Zadavatel a zdravotnické zařízení mohou předávat osobní údaje podle této smlouvy svým třetím stranám, pokud takové třetí strany odůvodněně potřebují zpracovávat osobní údaje podle této smlouvy a pokud se na takové předání údajů vztahují příslušná smluvní omezení a pokud je takové předání provedeno podle platných právních předpisů o ochraně osobních údajů. Zadavatel a zdravotnické zařízení nebudou osobní údaje sdílet ani je nepředají mimo Evropský hospodářský prostor bez zajištění jejich dostatečné ochrany v souladu s platnými právními předpisy o ochraně osobních údajů.
Sample 1
PŘEDÁVÁNÍ ÚDAJŮ. Both prior to and during the course of the Study, the Investigator and the Study Personnel staff may provide PSI and/or the Sponsor with personal data. Such data may include names, contact information, bank account, work experience, qualifications, publications, resumés, educational background, performance information, facilities, staff capabilities, and other information relating to the Study (the “Personal Data”). The Investigator hereby consents to the processing (including use, disclosure or transfer) of his/her Personal Data by PSI, the Sponsor, their respective agents and Před i v průběhu Studie může být Hlavní zkoušející a Studijní personál požádán o poskytnutí osobních údajů PSI a (nebo)
Sample 1
PŘEDÁVÁNÍ ÚDAJŮ. Both prior to and during the conduct of the Trial the Trial Staff may provide Sponsor and its designee with their personal data (as defined under Applicable Law) (the “Personal Data”). Institution will ensure that all Trial Staff have consented in writing to the processing (including use, disclosure or transfer) of his/her Personal Data by Sponsor and its designee, and their respective agents and affiliates and national and foreign governmental or regulatory agencies for the following purposes (the “Purposes”): (a) the conduct of clinical trials; (b) review by governmental or regulatory agencies, Sponsor and its designees and its and their respective agents, and affiliates; (c) satisfying legal or regulatory requirements; and (d) storage in databases for use in selecting investigators and institutions for future clinical trials; and (e) the transfer of the Personal Data abroad, even if such Personal Data is transferred to countries that do not ensure an equivalent level of protection as in the country where the Trial is taking place. Institution represents and warrants that all Trial Staff have consented to the processing of their Personal Data for the Purposes, including the transfer to other countries not having an equivalent level of protection as the country where the Trial is taking place. Institution will notify Sponsor or its designee immediately in writing if such consent is withdrawn by any Trial Staff. During the course of the Trial and after its completion, Sponsor shall in case of Před zahájením Klinického hodnocení i během jeho provádění mohou Pracovníci klinického hodnocení poskytovat Zadavateli a jeho pověřenému zástupci osobní údaje (definované na základě Platných zákonů) (dále jen „Osobní údaje“). Poskytovatel zajistí, aby Pracovníci klinického hodnocení poskytli souhlas se zpracováním (včetně používání, zpřístupňování a předávání) svých Osobních údajů Zadavatelem a jím pověřenou osobou a jejich příslušnými zástupci a přidruženými subjekty a národními i zahraničními státními či kontrolními úřady pro následující účely (dále jen „Účely“): (a) provádění klinických hodnocení; (b) přezkoumání státními nebo kontrolními orgány, Zadavatelem a jím pověřenými osobami a jejich příslušnými zástupci a přidruženými subjekty; (c) uspokojení zákonných a regulačních požadavků, (d) uložení do databází za účelem využití při výběru zkoušejících a zdravotnických zařízení pro budoucí klinická hodnocení a (e) předávání Osobních údajů do zahraničí, a to i v přípa...
Sample 1
AutoNDA by SimpleDocs
PŘEDÁVÁNÍ ÚDAJŮ. Both prior to and during the course of the Study, Před i v průběhu Studie můžou být Hlavní the Investigator and the Study Personnel staff may provide PSI and/or the Sponsor with personal data. Such data may include names, contact information, bank account, work experience, qualifications, publications, resumés, educational background, performance information, facilities, staff capabilities, and other information relating to the Study (the “Personal Data”). The Investigator hereby consents to the processing (including use, disclosure or transfer) of his/her Personal Data by PSI, the Sponsor, their respective agents and affiliates and governmental or regulatory agencies both in the Czech Republic and abroad for the following purposes (the “Purposes”): (a) the conduct of clinical trials; (b) review by governmental or regulatory agencies, PSI, the Sponsor and their agents, and affiliates; (c) satisfying legal or regulatory requirements; and, (d) storage in databases for use in selecting investigators and institutions for future clinical trials. The Investigator also agrees to a transfer of his/her Personal Data abroad, even if such personal data is transferred to third countries which do not ensure at least the same level of personal data protection in its territory as that in force in the territory of the European Union are not recognized by the EU Commission. The Investigator and the Institution represent that all Study Personnel have consented to the processing of their Personal Data for the Purposes, including the transfer to third counties, and shall notify PSI immediately if such consent has been withdrawn.
Sample 1
PŘEDÁVÁNÍ ÚDAJŮ. Both prior to and during the course of the Study, the Investigator and the Study Personnel staff may provide PSI and/or the Sponsor with personal data. Such data may include names, contact information, bank account, work experience, qualifications, publications, resumés, educational background, performance information, facilities, staff capabilities, and other information relating to the Study (the “Personal Data”). The Investigator hereby consents to the processing (including use, disclosure or transfer) of his/her Personal Data by PSI, the Sponsor, their respective agents and affiliates and governmental or regulatory agencies both in the Czech Republic and abroad for the following purposes (the “Purposes”): (a) the conduct of clinical trials; (b) review by governmental or regulatory agencies, PSI, the Sponsor and their agents, and affiliates; (c) satisfying legal or regulatory requirements; and, (d) storage in databases for use in selecting investigators and institutions for future clinical trials. The Investigator also agrees to a transfer of his/her Před i v průběhu Studie může být Hlavní zkoušející a Studijní personál požádán o poskytnutí osobních údajů PSI a (nebo)
Sample 1

Related to PŘEDÁVÁNÍ ÚDAJŮ

  • Cost of Collection If default is made in the payment of this Note, Borrower shall pay the Holder hereof reasonable costs of collection, including reasonable attorneys' fees.

  • Fees, Expenses, etc All fees and other compensation required to be paid to each Agent or the Lenders pursuant hereto or pursuant to any other written agreement on or prior to the Closing Date shall have been paid or received.

  • Payment of Other Taxes by Xxxxxxxx The Borrower shall timely pay to the relevant Governmental Authority in accordance with Applicable Law, or at the option of the Administrative Agent timely reimburse it for the payment of, any Other Taxes.

  • Servicing Fees As compensation for its servicing activities and as reimbursement for its reasonable expenses in connection therewith, the Servicer shall be entitled to receive the Servicing Fees monthly on each Settlement Date. Such Servicing Fees shall be payable from available funds in accordance with Section 2.07 and 2.08 of the Funding Agreement. The Servicer shall be required to pay for all expenses incurred by it in connection with its activities hereunder (including any payments to accountants, counsel or any other Person) and shall not be entitled to any payment therefor other than the Servicing Fees.

  • Payment of Other Taxes by the Borrower The Borrower shall timely pay to the relevant Governmental Authority in accordance with applicable law, or at the option of the Administrative Agent timely reimburse it for the payment of, any Other Taxes.

  • Fees; Expenses As consideration for the services provided by the Warrant Agent (the “Services”), the Company shall pay to the Warrant Agent the fees set forth on Schedule 1 hereto (the “Fees”). If the Company requests that the Warrant Agent provide additional services not contemplated hereby, the Company shall pay to the Warrant Agent fees for such services at the Warrant Agent’s reasonable and customary rates, such fees to be governed by the terms of a separate agreement to be mutually agreed to and entered into by the Parties at such time (the “Additional Service Fee”; together with the Fees, the “Service Fees”) (a) The Company shall reimburse the Warrant Agent for all reasonable and documented expenses incurred by the Warrant Agent (including, without limitation, reasonable and documented fees and disbursements of counsel) in connection with the Services (the “Expenses”); provided, however, that the Warrant Agent reserves the right to request advance payment for any out-of-pocket expenses. The Company agrees to pay all Service Fees and Expenses within thirty (30) days following receipt of an invoice from the Warrant Agent. (b) The Company agrees and acknowledges that the Warrant Agent may adjust the Service Fees annually, on or about each anniversary date of this Agreement, by the annual percentage of change in the latest Consumer Price Index of All Urban Consumers United States City Average, as published by the U.S. Department of Labor, Bureau of Labor Statistics. (c) Upon termination of this Agreement for any reason, the Warrant Agent shall assist the Company with the transfer of records of the Company held by the Warrant Agent. The Warrant Agent shall be entitled to reasonable additional compensation and reimbursement of any Expenses for the preparation and delivery of such records to the successor agent or to the Company, and for maintaining records and/or Stock Certificates that are received after the termination of this Agreement (the “Record Transfer Services”).

  • Fees Charges All points, fees and charges (including finance charges) and whether or not financed, assessed, collected or to be collected in connection with the origination and servicing of each Mortgage Loan have been disclosed in writing to the Mortgagor in accordance with applicable state and federal law and regulation. This representation and warranty is a Deemed Material and Adverse Representation; and

  • Fees, etc On the Initial Borrowing Date, the Borrower shall have paid to the Administrative Agent and each Lender all costs, fees and expenses (including, without limitation, legal fees and expenses) and other compensation contemplated hereby payable to the Administrative Agent or such Lender to the extent then due.

  • Payment of Other Taxes by the Borrowers Without limiting the provisions of subsection (a) above, each Borrower shall timely pay any Other Taxes to the relevant Governmental Authority in accordance with applicable law.

  • Contract Amount Compensation amount(s), when stated in this Bid Specifications, shall not be construed as either the maximum or minimum amount which Department shall be obligated to accept as the result of this Bid Specifications or any Agreement entered into as a result of this Bid Specifications.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!